Irreversible electroporation of the liver: is there a safe limit to the ablation volume?

dc.contributor.authorSánchez Velázquez, Patricia
dc.contributor.authorCastellví, Quim
dc.contributor.authorVillanueva Garatachea, Alberto
dc.contributor.authorQuesada, Rita
dc.contributor.authorPañella, Clara
dc.contributor.authorCáceres, M.
dc.contributor.authorDorcaratto, D.
dc.contributor.authorAndaluz, Anna
dc.contributor.authorMoll, Xavier
dc.contributor.authorTrujillo, M.
dc.contributor.authorBurdío, J. M.
dc.contributor.authorBerjano, E.
dc.contributor.authorGrande, L.
dc.contributor.authorIvorra, Antoni
dc.contributor.authorBurdío, Fernando
dc.date.accessioned2018-12-11T10:22:33Z
dc.date.available2018-12-11T10:22:33Z
dc.date.issued2016-04-01
dc.date.updated2018-07-25T07:51:01Z
dc.description.abstractIrreversible electroporation is a fast-growing liver ablation technique. Although safety has been well documented in small ablations, our aim is to assess its safety and feasibility when a large portion of liver is ablated. Eighty-seven mice were subjected to high voltage pulses directly delivered across parallel plate electrodes comprising around 40% of mouse liver. One group consisted in 55 athymicnude, in which a tumor from the KM12C cell line was grown and the other thirty-two C57-Bl6 nontumoral mice. Both groups were subsequently divided into subsets according to the delivered field strength (1000 V/cm, 2000 V/cm) and whether or not they received anti-hyperkalemia therapy. Early mortality (less than 24 hours post-IRE) in the 2000 V/cm group was observed and revealed considerably higher mean potassium levels. In contrast, the animals subjected to a 2000 V/cm field treated with the anti-hyperkalemia therapy had higher survival rates (OR = 0.1, 95%CI = 0.02-0.32, p < 0.001). Early mortality also depended on the electric field magnitude of the IRE protocol, as mice given 1000 V/cm survived longer than those given 2000 V/cm (OR = 4.7, 95% CI = 1.8-11.8, p = 0.001). Our findings suggest that ionic disturbances, mainly due to potassium alterations, should be warned and envisioned when large volume ablations are performed by IRE.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid27032535
dc.identifier.urihttps://hdl.handle.net/2445/126869
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/srep23781
dc.relation.ispartofScientific Reports, 2016, vol. 6
dc.relation.urihttps://doi.org/10.1038/srep23781
dc.rightscc by (c) Sánchez Velázquez et al., 2016
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationMortalitat
dc.subject.classificationMalalties del fetge
dc.subject.otherMortality
dc.subject.otherLiver diseases
dc.titleIrreversible electroporation of the liver: is there a safe limit to the ablation volume?
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Sanchez-VelazquezP.pdf
Mida:
692.79 KB
Format:
Adobe Portable Document Format